Open-access paper: https://bit.ly/3T6ddMb
Full release: https://bit.ly/46oZrYo
#HFrEF #SGK1
Open-access paper: https://bit.ly/3T6ddMb
Full release: https://bit.ly/46oZrYo
#HFrEF #SGK1
#パワースポット #ボルテックス #アリゾナ州 #サトルボディ #ベルロック #33rdパラレル #ピンチャート #オハイオ州 #サーペントマウンド #SerpentMound #クリスタルスカル #セドナ #シャスタ #レイライン #ダウンジングロッド #ヤイエル文明 #yahyel #パラレルリアリティ #チャネリング #オープンコンタクト #ピラミッド #聖地 #bashar #スピリチュアル
www.youtube.com/watch?v=THRv...
#パワースポット #ボルテックス #アリゾナ州 #サトルボディ #ベルロック #33rdパラレル #ピンチャート #オハイオ州 #サーペントマウンド #SerpentMound #クリスタルスカル #セドナ #シャスタ #レイライン #ダウンジングロッド #ヤイエル文明 #yahyel #パラレルリアリティ #チャネリング #オープンコンタクト #ピラミッド #聖地 #bashar #スピリチュアル
www.youtube.com/watch?v=THRv...
ejournals.uni-muenster.de/thrv/article...
ejournals.uni-muenster.de/thrv/article...
📅 June 2–4 📍 New York 🤝 1:1 investor meetings
Updates on our SGK1 platform: Wave II Phase 2/3 in LQTS, Fast Track for THRV-1268, Phase 2a in HFrEF on deck.
#JefferiesHealthcare #SGK1
📅 June 2–4 📍 New York 🤝 1:1 investor meetings
Updates on our SGK1 platform: Wave II Phase 2/3 in LQTS, Fast Track for THRV-1268, Phase 2a in HFrEF on deck.
#JefferiesHealthcare #SGK1
📅 Mon, May 18 · 1:15 PM ET 📍 NYC
We'll share updates on our SGK1 pipeline: Phase 2/3 in LQTS, Fast Track for THRV-1268, Phase 2a in HFrEF coming.
Meet: admin@thryvtrx.com
#UBSHealthcare #SGK1
📅 Mon, May 18 · 1:15 PM ET 📍 NYC
We'll share updates on our SGK1 pipeline: Phase 2/3 in LQTS, Fast Track for THRV-1268, Phase 2a in HFrEF coming.
Meet: admin@thryvtrx.com
#UBSHealthcare #SGK1
🟢 First patient enrolled in Wave II (Phase 2/3, LQTS Type 2).
🟢 FDA Fast Track Designation granted for THRV-1268. Initial data expected Q4 2026.
Full PR: https://bit.ly/4vGYlCw
#LQTS #RareDisease #FastTrack #Cardiology #Biotech
🟢 First patient enrolled in Wave II (Phase 2/3, LQTS Type 2).
🟢 FDA Fast Track Designation granted for THRV-1268. Initial data expected Q4 2026.
Full PR: https://bit.ly/4vGYlCw
#LQTS #RareDisease #FastTrack #Cardiology #Biotech
🔗 www.newswire.ca/news-release...
🔗 www.newswire.ca/news-release...
With deep expertise in cardiovascular & genetic diseases, Matt will help drive our BD strategy and advance THRV-1268 toward Phase 2/3.
Link: loom.ly/4kCC3Oo
#SGK1 #Cardiology #Biotech #LQTS #HeartFailure #AFib
With deep expertise in cardiovascular & genetic diseases, Matt will help drive our BD strategy and advance THRV-1268 toward Phase 2/3.
Link: loom.ly/4kCC3Oo
#SGK1 #Cardiology #Biotech #LQTS #HeartFailure #AFib
Read more: www.newswire.ca/news-release...
#SGK1 #Cardiology #Biotech #LQTS #HeartFailure #AFib
Read more: www.newswire.ca/news-release...
#SGK1 #Cardiology #Biotech #LQTS #HeartFailure #AFib
📍 Nov 8–10 | New Orleans
Read more: loom.ly/gXgaJEQ
#CardioResearch #HeartFailure
📍 Nov 8–10 | New Orleans
Read more: loom.ly/gXgaJEQ
#CardioResearch #HeartFailure
👉 loom.ly/tZj96M8
#SGK1 #LQTS #Biotech
👉 loom.ly/tZj96M8
#SGK1 #LQTS #Biotech
🗓️ Aug 30 – Heart Failure | Dr. Saumya Das
🗓️ Aug 31 – LQTS | Dr. Simona Casini
Details 👉 loom.ly/LPHc97A
#SGK1 #Cardiology
🗓️ Aug 30 – Heart Failure | Dr. Saumya Das
🗓️ Aug 31 – LQTS | Dr. Simona Casini
Details 👉 loom.ly/LPHc97A
#SGK1 #Cardiology
After all, they say it's all thrv fo gor their own pay rises.🙄
After all, they say it's all thrv fo gor their own pay rises.🙄